JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1195423, encodeId=745d119542393, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2021年9月23日投稿，中间大修了2次，2022年2月初录用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bbf02235786, createdName=12132b34m27(暂无昵称), createdTime=Sun Feb 20 20:06:40 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200723, encodeId=6df71200e23ef, content=请问文章能共一吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=540f5697120, createdName=ms8000000826918239, createdTime=Tue Mar 08 23:07:18 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200633, encodeId=70571200633da, content=10.18提交，11.7Under review，11.9 awaiting reviewer assignment，11.26 awaiting AE recommendation, 12.19 awaiting DE decision, 12.20 Transfer Out Pending. 整体效率还是挺高的，送了两个审稿人，一个给了修改意见，一个说创新性不行，编辑就直接给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71574749683, createdName=1529826491, createdTime=Tue Mar 08 18:14:45 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198826, encodeId=1c96119882630, content=需要审稿费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Mar 02 19:37:18 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195644, encodeId=57911195644fb, content=投稿命中率:25.0 经验分享：临床胶囊内镜方向送稿后4天拒稿，说明只有10%的投稿会接收。 Due to the growth of the Journal and the increase in submissions we are only able to publish 10% of all the manuscripts submitted to us., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Mon Feb 21 12:17:12 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093214, encodeId=abf81093214f1, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093213, encodeId=56441093213dd, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591284, encodeId=1599591284ae, content=Awaiting reviewer assignment 近3周，今天看已经是awaiting DE decision的状态了……是不是凉凉了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970785, encodeId=51349e078522, content=投稿至今18天，我先是under review，然后又变成了awaiting reviewer assignment，这是什么意思？没找到审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8KImyUciaABZEvaTQeoyp7eAqKlbd2m0N1NibZjQQ3KaelqZwMl9pCeTlP6eKUDSIDtlwAbzBcorQ/132, createdBy=ceec2538475, createdName=丙丙, createdTime=Fri Jun 04 09:02:41 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056719, encodeId=5b441056e19f6, content=请问这个杂志接受个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2604748751, createdName=guoruixue86, createdTime=Fri Oct 01 09:58:08 CST 2021, time=2021-10-01, status=1, ipAttribution=)]

2022-02-20 12132b34m27(暂无昵称)

审稿速度:6.0 | 投稿命中率:50.0
经验分享：2021年9月23日投稿，中间大修了2次，2022年2月初录用。

114 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1195423, encodeId=745d119542393, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2021年9月23日投稿，中间大修了2次，2022年2月初录用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bbf02235786, createdName=12132b34m27(暂无昵称), createdTime=Sun Feb 20 20:06:40 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200723, encodeId=6df71200e23ef, content=请问文章能共一吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=540f5697120, createdName=ms8000000826918239, createdTime=Tue Mar 08 23:07:18 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200633, encodeId=70571200633da, content=10.18提交，11.7Under review，11.9 awaiting reviewer assignment，11.26 awaiting AE recommendation, 12.19 awaiting DE decision, 12.20 Transfer Out Pending. 整体效率还是挺高的，送了两个审稿人，一个给了修改意见，一个说创新性不行，编辑就直接给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71574749683, createdName=1529826491, createdTime=Tue Mar 08 18:14:45 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198826, encodeId=1c96119882630, content=需要审稿费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Mar 02 19:37:18 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195644, encodeId=57911195644fb, content=投稿命中率:25.0 经验分享：临床胶囊内镜方向送稿后4天拒稿，说明只有10%的投稿会接收。 Due to the growth of the Journal and the increase in submissions we are only able to publish 10% of all the manuscripts submitted to us., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Mon Feb 21 12:17:12 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093214, encodeId=abf81093214f1, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093213, encodeId=56441093213dd, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591284, encodeId=1599591284ae, content=Awaiting reviewer assignment 近3周，今天看已经是awaiting DE decision的状态了……是不是凉凉了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970785, encodeId=51349e078522, content=投稿至今18天，我先是under review，然后又变成了awaiting reviewer assignment，这是什么意思？没找到审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8KImyUciaABZEvaTQeoyp7eAqKlbd2m0N1NibZjQQ3KaelqZwMl9pCeTlP6eKUDSIDtlwAbzBcorQ/132, createdBy=ceec2538475, createdName=丙丙, createdTime=Fri Jun 04 09:02:41 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056719, encodeId=5b441056e19f6, content=请问这个杂志接受个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2604748751, createdName=guoruixue86, createdTime=Fri Oct 01 09:58:08 CST 2021, time=2021-10-01, status=1, ipAttribution=)]

2022-03-08 ms8000000826918239

请问文章能共一吗

110 0

[GetPortalCommentsPageByObjectIdResponse(id=1195423, encodeId=745d119542393, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2021年9月23日投稿，中间大修了2次，2022年2月初录用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bbf02235786, createdName=12132b34m27(暂无昵称), createdTime=Sun Feb 20 20:06:40 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200723, encodeId=6df71200e23ef, content=请问文章能共一吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=540f5697120, createdName=ms8000000826918239, createdTime=Tue Mar 08 23:07:18 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200633, encodeId=70571200633da, content=10.18提交，11.7Under review，11.9 awaiting reviewer assignment，11.26 awaiting AE recommendation, 12.19 awaiting DE decision, 12.20 Transfer Out Pending. 整体效率还是挺高的，送了两个审稿人，一个给了修改意见，一个说创新性不行，编辑就直接给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71574749683, createdName=1529826491, createdTime=Tue Mar 08 18:14:45 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198826, encodeId=1c96119882630, content=需要审稿费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Mar 02 19:37:18 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195644, encodeId=57911195644fb, content=投稿命中率:25.0 经验分享：临床胶囊内镜方向送稿后4天拒稿，说明只有10%的投稿会接收。 Due to the growth of the Journal and the increase in submissions we are only able to publish 10% of all the manuscripts submitted to us., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Mon Feb 21 12:17:12 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093214, encodeId=abf81093214f1, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093213, encodeId=56441093213dd, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591284, encodeId=1599591284ae, content=Awaiting reviewer assignment 近3周，今天看已经是awaiting DE decision的状态了……是不是凉凉了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970785, encodeId=51349e078522, content=投稿至今18天，我先是under review，然后又变成了awaiting reviewer assignment，这是什么意思？没找到审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8KImyUciaABZEvaTQeoyp7eAqKlbd2m0N1NibZjQQ3KaelqZwMl9pCeTlP6eKUDSIDtlwAbzBcorQ/132, createdBy=ceec2538475, createdName=丙丙, createdTime=Fri Jun 04 09:02:41 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056719, encodeId=5b441056e19f6, content=请问这个杂志接受个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2604748751, createdName=guoruixue86, createdTime=Fri Oct 01 09:58:08 CST 2021, time=2021-10-01, status=1, ipAttribution=)]

2022-03-08 1529826491

10.18提交，11.7Under review，11.9 awaiting reviewer assignment，11.26 awaiting AE recommendation,
12.19 awaiting DE decision, 12.20 Transfer Out Pending. 整体效率还是挺高的，送了两个审稿人，一个给了修改意见，一个说创新性不行，编辑就直接给拒了。

102 0

[GetPortalCommentsPageByObjectIdResponse(id=1195423, encodeId=745d119542393, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2021年9月23日投稿，中间大修了2次，2022年2月初录用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bbf02235786, createdName=12132b34m27(暂无昵称), createdTime=Sun Feb 20 20:06:40 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200723, encodeId=6df71200e23ef, content=请问文章能共一吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=540f5697120, createdName=ms8000000826918239, createdTime=Tue Mar 08 23:07:18 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200633, encodeId=70571200633da, content=10.18提交，11.7Under review，11.9 awaiting reviewer assignment，11.26 awaiting AE recommendation, 12.19 awaiting DE decision, 12.20 Transfer Out Pending. 整体效率还是挺高的，送了两个审稿人，一个给了修改意见，一个说创新性不行，编辑就直接给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71574749683, createdName=1529826491, createdTime=Tue Mar 08 18:14:45 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198826, encodeId=1c96119882630, content=需要审稿费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Mar 02 19:37:18 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195644, encodeId=57911195644fb, content=投稿命中率:25.0 经验分享：临床胶囊内镜方向送稿后4天拒稿，说明只有10%的投稿会接收。 Due to the growth of the Journal and the increase in submissions we are only able to publish 10% of all the manuscripts submitted to us., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Mon Feb 21 12:17:12 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093214, encodeId=abf81093214f1, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093213, encodeId=56441093213dd, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591284, encodeId=1599591284ae, content=Awaiting reviewer assignment 近3周，今天看已经是awaiting DE decision的状态了……是不是凉凉了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970785, encodeId=51349e078522, content=投稿至今18天，我先是under review，然后又变成了awaiting reviewer assignment，这是什么意思？没找到审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8KImyUciaABZEvaTQeoyp7eAqKlbd2m0N1NibZjQQ3KaelqZwMl9pCeTlP6eKUDSIDtlwAbzBcorQ/132, createdBy=ceec2538475, createdName=丙丙, createdTime=Fri Jun 04 09:02:41 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056719, encodeId=5b441056e19f6, content=请问这个杂志接受个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2604748751, createdName=guoruixue86, createdTime=Fri Oct 01 09:58:08 CST 2021, time=2021-10-01, status=1, ipAttribution=)]

2022-03-02 13007594m29暂无昵称

需要审稿费吗？

89 0

[GetPortalCommentsPageByObjectIdResponse(id=1195423, encodeId=745d119542393, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2021年9月23日投稿，中间大修了2次，2022年2月初录用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bbf02235786, createdName=12132b34m27(暂无昵称), createdTime=Sun Feb 20 20:06:40 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200723, encodeId=6df71200e23ef, content=请问文章能共一吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=540f5697120, createdName=ms8000000826918239, createdTime=Tue Mar 08 23:07:18 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200633, encodeId=70571200633da, content=10.18提交，11.7Under review，11.9 awaiting reviewer assignment，11.26 awaiting AE recommendation, 12.19 awaiting DE decision, 12.20 Transfer Out Pending. 整体效率还是挺高的，送了两个审稿人，一个给了修改意见，一个说创新性不行，编辑就直接给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71574749683, createdName=1529826491, createdTime=Tue Mar 08 18:14:45 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198826, encodeId=1c96119882630, content=需要审稿费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Mar 02 19:37:18 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195644, encodeId=57911195644fb, content=投稿命中率:25.0 经验分享：临床胶囊内镜方向送稿后4天拒稿，说明只有10%的投稿会接收。 Due to the growth of the Journal and the increase in submissions we are only able to publish 10% of all the manuscripts submitted to us., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Mon Feb 21 12:17:12 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093214, encodeId=abf81093214f1, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093213, encodeId=56441093213dd, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591284, encodeId=1599591284ae, content=Awaiting reviewer assignment 近3周，今天看已经是awaiting DE decision的状态了……是不是凉凉了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970785, encodeId=51349e078522, content=投稿至今18天，我先是under review，然后又变成了awaiting reviewer assignment，这是什么意思？没找到审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8KImyUciaABZEvaTQeoyp7eAqKlbd2m0N1NibZjQQ3KaelqZwMl9pCeTlP6eKUDSIDtlwAbzBcorQ/132, createdBy=ceec2538475, createdName=丙丙, createdTime=Fri Jun 04 09:02:41 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056719, encodeId=5b441056e19f6, content=请问这个杂志接受个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2604748751, createdName=guoruixue86, createdTime=Fri Oct 01 09:58:08 CST 2021, time=2021-10-01, status=1, ipAttribution=)]

2022-02-21 ms2000000713462597

投稿命中率:25.0
经验分享：临床胶囊内镜方向送稿后4天拒稿，说明只有10%的投稿会接收。
Due to the growth of the Journal and the increase in submissions we are only able to publish 10% of all the manuscripts submitted to us.

61 0

[GetPortalCommentsPageByObjectIdResponse(id=1195423, encodeId=745d119542393, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2021年9月23日投稿，中间大修了2次，2022年2月初录用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bbf02235786, createdName=12132b34m27(暂无昵称), createdTime=Sun Feb 20 20:06:40 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200723, encodeId=6df71200e23ef, content=请问文章能共一吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=540f5697120, createdName=ms8000000826918239, createdTime=Tue Mar 08 23:07:18 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200633, encodeId=70571200633da, content=10.18提交，11.7Under review，11.9 awaiting reviewer assignment，11.26 awaiting AE recommendation, 12.19 awaiting DE decision, 12.20 Transfer Out Pending. 整体效率还是挺高的，送了两个审稿人，一个给了修改意见，一个说创新性不行，编辑就直接给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71574749683, createdName=1529826491, createdTime=Tue Mar 08 18:14:45 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198826, encodeId=1c96119882630, content=需要审稿费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Mar 02 19:37:18 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195644, encodeId=57911195644fb, content=投稿命中率:25.0 经验分享：临床胶囊内镜方向送稿后4天拒稿，说明只有10%的投稿会接收。 Due to the growth of the Journal and the increase in submissions we are only able to publish 10% of all the manuscripts submitted to us., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Mon Feb 21 12:17:12 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093214, encodeId=abf81093214f1, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093213, encodeId=56441093213dd, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591284, encodeId=1599591284ae, content=Awaiting reviewer assignment 近3周，今天看已经是awaiting DE decision的状态了……是不是凉凉了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970785, encodeId=51349e078522, content=投稿至今18天，我先是under review，然后又变成了awaiting reviewer assignment，这是什么意思？没找到审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8KImyUciaABZEvaTQeoyp7eAqKlbd2m0N1NibZjQQ3KaelqZwMl9pCeTlP6eKUDSIDtlwAbzBcorQ/132, createdBy=ceec2538475, createdName=丙丙, createdTime=Fri Jun 04 09:02:41 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056719, encodeId=5b441056e19f6, content=请问这个杂志接受个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2604748751, createdName=guoruixue86, createdTime=Fri Oct 01 09:58:08 CST 2021, time=2021-10-01, status=1, ipAttribution=)]

2021-12-29 乌云背后的幸福线

是否需要在讨论中说明文章局限性？

55 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1195423, encodeId=745d119542393, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2021年9月23日投稿，中间大修了2次，2022年2月初录用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bbf02235786, createdName=12132b34m27(暂无昵称), createdTime=Sun Feb 20 20:06:40 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200723, encodeId=6df71200e23ef, content=请问文章能共一吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=540f5697120, createdName=ms8000000826918239, createdTime=Tue Mar 08 23:07:18 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200633, encodeId=70571200633da, content=10.18提交，11.7Under review，11.9 awaiting reviewer assignment，11.26 awaiting AE recommendation, 12.19 awaiting DE decision, 12.20 Transfer Out Pending. 整体效率还是挺高的，送了两个审稿人，一个给了修改意见，一个说创新性不行，编辑就直接给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71574749683, createdName=1529826491, createdTime=Tue Mar 08 18:14:45 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198826, encodeId=1c96119882630, content=需要审稿费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Mar 02 19:37:18 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195644, encodeId=57911195644fb, content=投稿命中率:25.0 经验分享：临床胶囊内镜方向送稿后4天拒稿，说明只有10%的投稿会接收。 Due to the growth of the Journal and the increase in submissions we are only able to publish 10% of all the manuscripts submitted to us., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Mon Feb 21 12:17:12 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093214, encodeId=abf81093214f1, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093213, encodeId=56441093213dd, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591284, encodeId=1599591284ae, content=Awaiting reviewer assignment 近3周，今天看已经是awaiting DE decision的状态了……是不是凉凉了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970785, encodeId=51349e078522, content=投稿至今18天，我先是under review，然后又变成了awaiting reviewer assignment，这是什么意思？没找到审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8KImyUciaABZEvaTQeoyp7eAqKlbd2m0N1NibZjQQ3KaelqZwMl9pCeTlP6eKUDSIDtlwAbzBcorQ/132, createdBy=ceec2538475, createdName=丙丙, createdTime=Fri Jun 04 09:02:41 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056719, encodeId=5b441056e19f6, content=请问这个杂志接受个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2604748751, createdName=guoruixue86, createdTime=Fri Oct 01 09:58:08 CST 2021, time=2021-10-01, status=1, ipAttribution=)]

2021-12-29 小动量

文章的局限性是什么？

67 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1195423, encodeId=745d119542393, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2021年9月23日投稿，中间大修了2次，2022年2月初录用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bbf02235786, createdName=12132b34m27(暂无昵称), createdTime=Sun Feb 20 20:06:40 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200723, encodeId=6df71200e23ef, content=请问文章能共一吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=540f5697120, createdName=ms8000000826918239, createdTime=Tue Mar 08 23:07:18 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200633, encodeId=70571200633da, content=10.18提交，11.7Under review，11.9 awaiting reviewer assignment，11.26 awaiting AE recommendation, 12.19 awaiting DE decision, 12.20 Transfer Out Pending. 整体效率还是挺高的，送了两个审稿人，一个给了修改意见，一个说创新性不行，编辑就直接给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71574749683, createdName=1529826491, createdTime=Tue Mar 08 18:14:45 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198826, encodeId=1c96119882630, content=需要审稿费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Mar 02 19:37:18 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195644, encodeId=57911195644fb, content=投稿命中率:25.0 经验分享：临床胶囊内镜方向送稿后4天拒稿，说明只有10%的投稿会接收。 Due to the growth of the Journal and the increase in submissions we are only able to publish 10% of all the manuscripts submitted to us., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Mon Feb 21 12:17:12 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093214, encodeId=abf81093214f1, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093213, encodeId=56441093213dd, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591284, encodeId=1599591284ae, content=Awaiting reviewer assignment 近3周，今天看已经是awaiting DE decision的状态了……是不是凉凉了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970785, encodeId=51349e078522, content=投稿至今18天，我先是under review，然后又变成了awaiting reviewer assignment，这是什么意思？没找到审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8KImyUciaABZEvaTQeoyp7eAqKlbd2m0N1NibZjQQ3KaelqZwMl9pCeTlP6eKUDSIDtlwAbzBcorQ/132, createdBy=ceec2538475, createdName=丙丙, createdTime=Fri Jun 04 09:02:41 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056719, encodeId=5b441056e19f6, content=请问这个杂志接受个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2604748751, createdName=guoruixue86, createdTime=Fri Oct 01 09:58:08 CST 2021, time=2021-10-01, status=1, ipAttribution=)]

2020-05-20 兮牧歌

Awaiting reviewer assignment 近3周，今天看已经是awaiting DE decision的状态了……是不是凉凉了……

156 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1195423, encodeId=745d119542393, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2021年9月23日投稿，中间大修了2次，2022年2月初录用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bbf02235786, createdName=12132b34m27(暂无昵称), createdTime=Sun Feb 20 20:06:40 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200723, encodeId=6df71200e23ef, content=请问文章能共一吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=540f5697120, createdName=ms8000000826918239, createdTime=Tue Mar 08 23:07:18 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200633, encodeId=70571200633da, content=10.18提交，11.7Under review，11.9 awaiting reviewer assignment，11.26 awaiting AE recommendation, 12.19 awaiting DE decision, 12.20 Transfer Out Pending. 整体效率还是挺高的，送了两个审稿人，一个给了修改意见，一个说创新性不行，编辑就直接给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71574749683, createdName=1529826491, createdTime=Tue Mar 08 18:14:45 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198826, encodeId=1c96119882630, content=需要审稿费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Mar 02 19:37:18 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195644, encodeId=57911195644fb, content=投稿命中率:25.0 经验分享：临床胶囊内镜方向送稿后4天拒稿，说明只有10%的投稿会接收。 Due to the growth of the Journal and the increase in submissions we are only able to publish 10% of all the manuscripts submitted to us., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Mon Feb 21 12:17:12 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093214, encodeId=abf81093214f1, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093213, encodeId=56441093213dd, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591284, encodeId=1599591284ae, content=Awaiting reviewer assignment 近3周，今天看已经是awaiting DE decision的状态了……是不是凉凉了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970785, encodeId=51349e078522, content=投稿至今18天，我先是under review，然后又变成了awaiting reviewer assignment，这是什么意思？没找到审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8KImyUciaABZEvaTQeoyp7eAqKlbd2m0N1NibZjQQ3KaelqZwMl9pCeTlP6eKUDSIDtlwAbzBcorQ/132, createdBy=ceec2538475, createdName=丙丙, createdTime=Fri Jun 04 09:02:41 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056719, encodeId=5b441056e19f6, content=请问这个杂志接受个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2604748751, createdName=guoruixue86, createdTime=Fri Oct 01 09:58:08 CST 2021, time=2021-10-01, status=1, ipAttribution=)]

2021-06-04 丙丙

投稿至今18天，我先是under review，然后又变成了awaiting reviewer assignment，这是什么意思？没找到审稿人吗？

82 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1195423, encodeId=745d119542393, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2021年9月23日投稿，中间大修了2次，2022年2月初录用。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bbf02235786, createdName=12132b34m27(暂无昵称), createdTime=Sun Feb 20 20:06:40 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200723, encodeId=6df71200e23ef, content=请问文章能共一吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=540f5697120, createdName=ms8000000826918239, createdTime=Tue Mar 08 23:07:18 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200633, encodeId=70571200633da, content=10.18提交，11.7Under review，11.9 awaiting reviewer assignment，11.26 awaiting AE recommendation, 12.19 awaiting DE decision, 12.20 Transfer Out Pending. 整体效率还是挺高的，送了两个审稿人，一个给了修改意见，一个说创新性不行，编辑就直接给拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71574749683, createdName=1529826491, createdTime=Tue Mar 08 18:14:45 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198826, encodeId=1c96119882630, content=需要审稿费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ecc3428987, createdName=13007594m29暂无昵称, createdTime=Wed Mar 02 19:37:18 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195644, encodeId=57911195644fb, content=投稿命中率:25.0 经验分享：临床胶囊内镜方向送稿后4天拒稿，说明只有10%的投稿会接收。 Due to the growth of the Journal and the increase in submissions we are only able to publish 10% of all the manuscripts submitted to us., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Mon Feb 21 12:17:12 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093214, encodeId=abf81093214f1, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093213, encodeId=56441093213dd, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591284, encodeId=1599591284ae, content=Awaiting reviewer assignment 近3周，今天看已经是awaiting DE decision的状态了……是不是凉凉了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970785, encodeId=51349e078522, content=投稿至今18天，我先是under review，然后又变成了awaiting reviewer assignment，这是什么意思？没找到审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK8KImyUciaABZEvaTQeoyp7eAqKlbd2m0N1NibZjQQ3KaelqZwMl9pCeTlP6eKUDSIDtlwAbzBcorQ/132, createdBy=ceec2538475, createdName=丙丙, createdTime=Fri Jun 04 09:02:41 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056719, encodeId=5b441056e19f6, content=请问这个杂志接受个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2604748751, createdName=guoruixue86, createdTime=Fri Oct 01 09:58:08 CST 2021, time=2021-10-01, status=1, ipAttribution=)]

2021-10-01 guoruixue86

请问这个杂志接受个案吗

61 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务